DCPH - Deciphera Pharmaceuticals LLC - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

Deciphera Pharmaceuticals LLC's activity chart (see below) currently has 139 price targets and 114 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 67.06% of the time, taking 209.38 days on average.

Most recent stock forecast was given by BRADLEY CANINO from GUGGENHEIM on 10-May-2024. First documented stock forecast 23-Oct-2017.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 31-Oct-2023

$23

$23

2 years 6 months 12 days ago
(10-May-2024)

5/8 (62.5%)

$-2.36 (-9.31%)

108

Sell Since 04-Jan-2023

$26

2 years 6 months 23 days ago
(30-Apr-2024)

2/7 (28.57%)

$0.73 (2.89%)

324

Buy Since 30-Apr-2024

$22

2 years 6 months 23 days ago
(30-Apr-2024)

2/3 (66.67%)

$2.24 (11.34%)

67

Buy Since 29-Apr-2024

$25

$23

2 years 6 months 24 days ago
(29-Apr-2024)

16/26 (61.54%)

$-0.28 (-1.11%)

205

Hold Since 29-Apr-2024

$23

2 years 6 months 24 days ago
(29-Apr-2024)

5/8 (62.5%)

$8.58 (59.50%)

354

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is DCPH (Deciphera Pharmaceuticals LLC) average time for price targets to be met?

On average it took 209 days for the stock forecasts to be reached, with an average price target met ratio of 67.06%.

Which analyst most recently updated their price target on DCPH (Deciphera Pharmaceuticals LLC)?

Bradley Canino

Which analyst has the most public recommendations on DCPH (Deciphera Pharmaceuticals LLC)?

Bradley Canino works at GUGGENHEIM and has 24 price targets and 17 ratings on DCPH

Which analyst is the currently most bullish on DCPH (Deciphera Pharmaceuticals LLC)?

Konstantinos Aprilakis with the highest potential upside of $49.41

Which analyst is the currently most reserved on DCPH (Deciphera Pharmaceuticals LLC)?

Robyn Karnauskas with the lowest potential downside of -$15.59
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?